Ann Clin Med Res | Volume 2, Issue 2 | Review Article | Open Access
Lawrence M Agius*
Department of Pathology, Mater Dei Hospital, Tal-Qroqq, University of Malta Medical School, Malta
*Correspondance to: Lawrence M Agius
Fulltext PDFSystem profiles of tumor antigenicity are real models of presented constitution within the cooperative participation of a suppressed autoimmune response to the neoplastic cells. It is significant to view the immune privileged status of the neoplastic lesion as substantial redefinition models as projected in terms of a blind immune response. The simplification modules of induction towards tumor cells, and the integral tumor lesion, allow for the emergence of lymphocytes that fail to recognize neoantigens as terms of provoked suppression of the autoimmune response. Evasion of tumor cells from immunosurveillance is a complex group of strategies within the confined locus phenomenon of tumors that are simultaneous locally categorized and also spreading metastatic lesions. In this sense, the ongoing dynamics of tumor cell evasion utilize a huge repertoire of mechanisms that are persistently active during the processes of tumor cell growth and proliferation, and especially in the induction of both early and advanced stages of tumor metastatic spread.
Agius LM. Failed Tumor Immunoantigenicity is Expressed Suppression of an Autoimmunity in Defining Immune Privilege Status of the Lesion. Ann Clin Med Res. 2021; 2(2): 1026..